InvestorsHub Logo

diamondguru-one

05/21/19 7:01 PM

#141488 RE: wallstreethustler #141480

better "DD" is needed...............its right there....


BLACK and WHITE !!!!!!!!!!!! GEEEEEEEEEEEEEZ and everyone is posting the FACTS also !!!!!!!!!!!!!

diamondguru-one

05/21/19 7:12 PM

#141493 RE: wallstreethustler #141480

OK !!!!!!!! here it is "AGAIN" !!!!!!!!!!!!!

http://www.otcmarkets.com/financialReportViewer?id=220830

NOTES TO THE FINANCIAL STATEMENTS

Paula attended “Pontificia Universidad Javeriana” and majored in Business Administration with Emphasis in Banking and Finance as well as Labor Legislation and Social Security, Certified Financial Management and Certified International Business. Paula is fluent in both English and Spanish.

Paula is the General Manager of BioCann Pharma S.A.S. in Cali, Republic of Colombia (Appointed: October, 2018)

as well as the Operations Manager (Republic of Colombia operations) for Instadose Pharma S.A.S., a subsidiary of Instadose Pharm Corp.

BioCann has a 50/50 Partnership and Joint Venture Agreement with Instadose Pharma S.A.S.

Paula’s primary responsibilities include: Planning the general and specific objectives of the company in the short and long term, Control all planned activities to ensure correct execution and to make financial, administrative and personnel decisions.


BioCann Management in this communication with shareholders sets out an initial overview of their existing business interests and confirms that BioCann has an equal partnership with Instadose Pharma S.A.S. in Colombia, which is a subsidiary of Canadian based Instadose Pharma Corp. ("Instadose"), www.instadosepharma.com. BioCann has sole and exclusive rights with Instadose in Colombia in terms of their partnership agreements. Instadose also has significant and at present, unrelated Cannabis interests in Africa.

Instadose owns in a Joint Venture, a licensed processing and manufacturing facility which is GMP Certified and complies with EU Pharmacopoeia Standards. This facility with the necessary Laboratories is located in Bogota, Colombia, where it extracts the CBD Oil isolate in pharmaceutical grade as is required by BioCann.

BioCann is responsible for the sourcing and acquisition of the Cannabis a/k/a Biomass and from Licensed Growers in Colombia and in the Cundinamarca, Valle del Cauca and Antioquia regions. This is Biomass that is suitable for Pharma grade oil extraction, complying with the quality assurance and growing standard operating procedures as established by Instadose's scientific department.

BioCann at present will be generating its revenues and profits through the bulk sale of these various Pharmaceutical Grade CBD Oils through distribution channels in Colombia and throughout Latin America.


https://www.prnewswire.com/news-releases/gncc-capital-inc-updates-on-its-recently-acquired-colombian-cannabis-company-300813700.html